Literature DB >> 1348033

The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo.

R De Jong1, M Brouwer, B Hooibrink, T Van der Pouw-Kraan, F Miedema, R A Van Lier.   

Abstract

On the basis of expression of the T cell differentiation antigen CD27, human peripheral blood CD4+ memory cells can be divided into two subsets, a large CD45RA-CD27+ (82%) and a small CD45RA-CD27- (18%) population. Analysis of the functional properties of these memory T cell subsets showed that proliferative responses to the recall antigen tetanus toxoid (TT), shortly after booster immunization, were mainly confined to the CD27- population. Also, in atopic individuals, proliferative responses to allergens for which these individuals are sensitized, were limited to the CD45RA-CD27- population. After stimulation with CD3 monoclonal antibody and phorbol ester, CD27+ cells produced vast amounts of interleukin (IL)-2 but minimal amounts of IL-4, whereas in marked contrast, CD27- T cells secreted low levels of IL-2 and high levels of IL-4. The capacity of the vast majority of these latter cells to produce IL-4 was found to be a stable feature since high IL-4 secreting T cell clones were generated from the CD27- subset. These findings suggest that upon renewed as well as chronic antigenic stimulation in vivo, memory T cells acquire the CD45RA-CD27- phenotype and that, as a consequence, in this subset functionally differentiated CD4+ T cells are compartmentalized. Our results predict that analysis of the small CD27- subset of memory cells, that makes up approximately 10% of the peripheral blood T cell population, will provide information on the specificity and function of responding CD4+ T cells at a given point in time in healthy and diseased individuals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348033     DOI: 10.1002/eji.1830220418

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  44 in total

Review 1.  Human CD4+ T cell differentiation and effector function: implications for autoimmunity.

Authors:  L S Davis; H Schulze-Koops; P E Lipsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.

Authors:  T Messele; M Abdulkadir; A L Fontanet; B Petros; D Hamann; M Koot; M T Roos; P T Schellekens; F Miedema; T F Rinke de Wit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Corinna Trebst; Barbara Tucky; Tao Wei; Lijun Wu; Espen S Baekkevold; Hans Lassmann; Susan M Staugaitis; James J Campbell; Richard M Ransohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

4.  Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis.

Authors:  Jing Jiang; Xianyuan Wang; Xinjing Wang; Zhihong Cao; Yanhua Liu; Mei Dong; Aihua Tong; Xiaoxing Cheng
Journal:  J Clin Immunol       Date:  2010-07       Impact factor: 8.317

5.  Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.

Authors:  Michael A Kolber
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

6.  CD27- CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels.

Authors:  Asa Schiött; Malin Lindstedt; Bengt Johansson-Lindbom; Erwin Roggen; Carl A K Borrebaeck
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

7.  Differential expression of cytokine genes in CD27-positive and -negative CD4 lymphocyte subsets from healthy humans and rheumatoid arthritis patients.

Authors:  I Stonãns; E Stonãne; H Vogelsang; U Junker; L Jäger
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

8.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.

Authors:  Mojgan Ahmadzadeh; Steven A Rosenberg
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

9.  Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.

Authors:  T A Zikos; A D Donnenberg; R J Landreneau; J D Luketich; V S Donnenberg
Journal:  Cancer Immunol Immunother       Date:  2011-03-05       Impact factor: 6.968

10.  Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.

Authors:  R T Meijer; S Surachno; S L Yong; F J Bemelman; S Florquin; I J M Ten Berge; P T A Schellekens
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.